Savara
SVRA
#6175
Rank
A$1.49 B
Marketcap
A$7.29
Share price
4.55%
Change (1 day)
18.53%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.21 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.18 Billion a decrease over its 2024 earnings that were of -A$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.21 Billion19.42%
2025 -A$0.18 Billion23.94%
2024 -A$0.14 Billion75.29%
2023 -A$78.98 Million43.38%
2022 -A$55.09 Million-11.31%
2021 -A$62.11 Million-13.3%
2020 -A$71.64 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$99.23 Million105.54%
2017 -A$48.28 Million34.11%
2016 -A$36 Million-37.43%
2015 -A$57.53 Million38.81%
2014 -A$41.45 Million33.62%
2013 -A$31.02 Million38.49%
2012 -A$22.4 Million24.59%
2011 -A$17.98 Million-36.5%
2010 -A$28.31 Million-3.14%
2009 -A$29.23 Million-23.28%
2008 -A$38.1 Million8.52%
2007 -A$35.11 Million-34.14%
2006 -A$53.31 Million184.43%
2005 -A$18.74 Million90.75%
2004 -A$9.83 Million190.35%
2003 -A$3.39 Million11.64%
2002 -A$3.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.12 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.22 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA